Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18406583

Download in:

View as

General Info

PMID
18406583